EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

Innokenty M Mokhosoev iD, Dmitry V Astakhov iD, Alexander A Terentiev, Nurbubu T Moldogazieva iD

Cells · 26.11.2024 · 13 (23) · 1958

DOI: 10.3390/cells13231958 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.11.2024. Verfasst von Innokenty M Mokhosoev und 3 weiteren Autor:innen. Beteiligte Einrichtung: Independent Researcher, 108815 Moscow, Russia. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme System, Neoplasms, Polymorphism, Genetic. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 298 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cytochromes P450 (CYPs) are heme-containing oxidoreductase enzymes with mono-oxygenase activity. Human CYPs catalyze the oxidation of a great variety of chemicals, including xenobiotics, steroid hormones, vitamins, bile acids, procarcinogens, and drugs.

Findings

In our review article, we discuss recent data evidencing that the same CYP isoform can be involved in both bioactivation and detoxification reactions and convert the same substrate to different products. Conversely, different CYP isoforms can convert the same substrate, xenobiotic or procarcinogen, into either a more or less toxic product. These phenomena depend on the type of catalyzed reaction, substrate, tissue type, and biological species. Since the CYPs involved in bioactivation (CYP3A4, CYP1A1, CYP2D6, and CYP2C8) are primarily expressed in the liver, their metabolites can induce hepatotoxicity and hepatocarcinogenesis. Additionally, we discuss the role of drugs as CYP substrates, inducers, and inhibitors as well as the implication of nuclear receptors, efflux transporters, and drug–drug interactions in anticancer drug resistance. We highlight the molecular mechanisms underlying the development of hormone-sensitive cancers, including breast, ovarian, endometrial, and prostate cancers. Key players in these mechanisms are the 2,3- and 3,4-catechols of estrogens, which are formed by CYP1A1, CYP1A2, and CYP1B1. The catechols can also produce quinones, leading to the formation of toxic protein and DNA adducts that contribute to cancer progression. However, 2-hydroxy- and 4-hydroxy-estrogens and their O-methylated derivatives along with conjugated metabolites play cancer-protective roles. CYP17A1 and CYP11A1, which are involved in the biosynthesis of testosterone precursors, contribute to prostate cancer, whereas conversion of testosterone to 5α-dihydrotestosterone as well as sustained activation and mutation of the androgen receptor are implicated in metastatic castration-resistant prostate cancer (CRPC). CYP enzymatic activities are influenced by CYP gene polymorphisms, although a significant portion of them have no effects. However, CYP polymorphisms can determine poor, intermediate, rapid, and ultrarapid metabolizer genotypes, which can affect cancer and drug susceptibility. Despite limited statistically significant data, associations between CYP polymorphisms and cancer risk, tumor size, and metastatic status among various populations have been demonstrated.

Conclusions

The metabolic diversity and dual character of biological effects of CYPs underlie their implications in, preliminarily, hormone-sensitive cancers. Variations in CYP activities and CYP gene polymorphisms are implicated in the interindividual variability in cancer and drug susceptibility. The development of CYP inhibitors provides options for personalized anticancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 Enzyme SystemNeoplasmsPolymorphism, GeneticHumans

Stichwörter der Autor:innen

CYPsbioactivation vs. detoxificationdrugs as substrates, inducers, and inhibitorsgene polymorphismshormone-dependent cancersnuclear receptors and efflux transporters

Substanzen

Cytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Independent Researcher, 108815 Moscow, Russia.
  • Department of Biochemistry, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
  • Department of Biochemistry and Molecular Biology, N.I. Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

ORCID-Profile: Innokenty M Mokhosoev, Dmitry V Astakhov, Nurbubu T Moldogazieva

Zitieren

APA

Mokhosoev, I. M., Astakhov, D. V., Terentiev, A. A., & Moldogazieva, N. T. (2024). Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review. Cells, 13(23), 1958. https://doi.org/10.3390/cells13231958

Vancouver

Mokhosoev IM, Astakhov DV, Terentiev AA, Moldogazieva NT. Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review. Cells. 2024;13(23):1958. doi:10.3390/cells13231958

BibTeX
@article{Mokhosoev2024,
  author = {Mokhosoev, Innokenty M and Astakhov, Dmitry V and Terentiev, Alexander A and Moldogazieva, Nurbubu T},
  title = {Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {23},
  pages = {1958},
  doi = {10.3390/cells13231958}
}
Kostenlos starten →